Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Resverlogix Corp T.RVX

Alternate Symbol(s):  RVXCF

Resverlogix Corp. is a Canada-based late-stage biotechnology company. The Company is engaged in epigenetics, with a focus on developing therapies for the benefit of patients with chronic diseases. Its epigenetic therapies are designed to regulate the expression of disease-causing genes. The Company's clinical program is focused on evaluating its lead candidate apabetalone (RVX-208) for the treatment of cardiovascular disease and associated comorbidities, and post-COVID-19 conditions. RVX-208 is a small molecule that is a selective bromodomain and extra-terminal (BET) inhibitor. BET bromodomain inhibition is an epigenetic mechanism that can regulate disease-causing genes. RVX-208 is a BET inhibitor selective for the second bromodomain (BD2) within the BET proteins. It partners with EVERSANA, to support the commercialization of RVX-208 for cardiovascular disease, post-COVID-19 conditions, and pulmonary arterial hypertension in Canada and the United States.


TSX:RVX - Post by User

Comment by general360on Jun 08, 2022 9:07am
418 Views
Post# 34739637

RE:New Press Release posted by Stockhouse - June 8, 2022

RE:New Press Release posted by Stockhouse - June 8, 2022

Does that mean the brain trust at RVX finally figured out how our drug works?

sweet.  Seems like only yesterday we were announcing we are a bromodomain inhibitor. Accidentally of course.

By alll means, carry on with the research. Univerity of Resverlogix must be on semester break now, or summer break. 

My report card consists of 10+ years, 100+k GONE.  Sounds like a degree from bobo U.

you're right GV. Not the type of news anticipated heading into the dog and pony show.  They'd better have more.  although it's "suggested" we don't attend the AGM, anyone planning on trying to wedding crash?  I BetOnMyself they'll have at least the one armed guard. Probably for great reason this year. Maybe they should have 2.  Or more. 

get the pitchforks ready. DM is like the scarecrow, tin man and lion all wrapped in one. No heart, no courage and no brains. fcuking a$$hat.  

<< Previous
Bullboard Posts
Next >>